DNA mutations

#Breast cancer #DNA mutations #Drug therapy #Gene therapy #Prostate cancer #sympos

This week in Drug Discovery (13 – 17 October)

News round-up for 13 – 17 October by Bruno Quinney, Content Team at DDW.  This week’s top story comes from new research showing drug therapies could prevent hereditary diseases. Elsewhere, there have been major developments in cancer research and gene therapy could help combat hearing loss. … Read More

#News

#Breast cancer #Cancer research #DNA mutations #Epigenetics #Gene therapy #Oncology

New podcast shining a spotlight on cancer research developments

This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: The ‘dark matter’ behind cancer and Could this ‘Goldilocks’… Read More

#Cancer Research #News

DNA unwinding from histones
#Cancer research #DNA mutations #Epigenetics #Oncology

The ‘dark matter’ behind cancer

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong looks into recent research which may explain why cancers can become more aggressive. Researchers in London and Milan may have discovered why cancers can become more aggressive without relying only on DNA mutations. A lot… Read More

#Cancer Research #Exclusive Content

Monkeypox virus
#Antivirals #DNA mutations #Immunology / Virology & Vaccines #Monkeypox #Monkeypox vaccine #Virus mutation

Researchers reveal how monkeypox evolves to evade drugs 

A team of scientists has identified the specific mutations in the monkeypox virus that contribute to its continued infectiousness. Monkeypox has infected more than 77,000 people in more than 100 countries worldwide. Mutations have enabled the virus to grow stronger and smarter, evading antiviral drugs and… Read More

#News #Trending News

Genetic engineering
#Bowel cancer #Cancer #Cancer research #DNA #DNA mutations #Epigenetics #Oncology #Treatment outcomes

Epigenetics vital in predicting cancer drug outcomes 

Cancers can evolve to become more aggressive without relying only on DNA mutations, two major studies have revealed.  The research characterises an extra level of control of cancer gene activity within tumours, which the researchers describe as cancer’s ‘dark matter’.  The two studies showed how… Read More

#Cancer Research #News